Vellore Institute of Technology (VIT) is a private university located in&nbsp;Tamil Nadu, India. Founded in 1984, as Vellore Engineering College, the institution offers 20 undergraduate, 34 postgraduate, four integrated and four research programs. It has campuses in Vellore, Amravati, Bhopal and Chennai.

VIT is one of the top ranked private universities in India according to NIRF, THE and QS Rankings.&nbsp;Govt. of India has recognized&nbsp;VIT, Vellore as an&nbsp;Institution of Eminence. This has allowed VIT to take independent quality initiatives and move up in world ranking.

&nbsp;

&nbsp;

VIT University

Department of Biotechnology

School of Bio Sciences and Technology

Vellore Campus

Biomass Conversion and Biorefinery

Floral waste as a potential feedstock for biopolymer production by a novel strain Enterococcus gallinarum VITSS05: characterization and in silico docking studies

cleaner technologies and environmental policy

A sustainable approach for degrading Vellore Nattu kozhi feather waste, analytical amino acid profling and its computational studiesSuneetha Vuppu sathvika kamaraj Thushar suresh

<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chavda+VP&amp;cauthor_id=38556227">Vivek P Chavda</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-1">1</a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vuppu+S&amp;cauthor_id=38556227">Suneetha Vuppu</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-2">2</a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Balar+PC&amp;cauthor_id=38556227">Pankti C Balar</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-3">3</a>,&nbsp;,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bezbaruah+R&amp;cauthor_id=38556227">Rajashri Bezbaruah</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-5">5</a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Teli+D&amp;cauthor_id=38556227">Divya Teli</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-6">6</a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sharma+N&amp;cauthor_id=38556227">Nikita Sharma</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-4">4</a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Alom+S&amp;cauthor_id=38556227">Shahnaz Alom</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/38556227/#full-view-affiliation-7">7</a>&nbsp;<ul><li>PMID: 38556227</li><li>DOI: <a href="https://doi.org/10.1016/j.ijbiomac.2024.131219">10.1016/j.ijbiomac.2024.131219</a></li></ul><h2>Abstract</h2>Background: Propolis is a resinous compound that is obtained from honey bees. It consists of numerous chemical constituents that impart different therapeutic action. The heart is the core of the body and cardiovascular disease (CVD) is a burden for the human being. This article emphasizes how propolis is fruitful in the management of various CVDs.Scope and approach: This review focuses on how various constituents of the propolis (such as terpenes, flavonoids, phenolics, etc.) impart cardio protective actions.Key finding and conclusion: With the support of various clinical trials and research outcomes, it was concluded that propolis owns niche cardio protective properties that can be a boon for various cardiac problems (both in preventive and therapeutic action) such as atherosclerosis, excessive angiogenesis, hypertension, and many more.Keywords: Angiogenesis; Atherosclerosis; Heart failure; Inflammation; Propolis.

International journal of Biological macromolecules

Propolis in the management of cardiovascular disease

https://www.wiley.com/en-be/Nanocarrier+Vaccines%3A+Biopharmaceutics+Based+Fast+Track+Development-p-9781394174683

Nanovaccines for Veterinary Applications  Suneetha Vuppu, Vivek P. Chavda, Toshika Mishra

Expert Review of Vaccines

Combatting infectious diarrhea: innovations in treatment and vaccination strategies

Viral Vector–Based Nanoparticles 195 Suneetha Vuppu, Vivek P. Chavda, Toshika Mishra, Oishani Sengupta, Anand Sairam, Paridhi Soni, Mohit Joshi, Bhumi Bhalodiya and Raj V.6.1 Introduction 1966.2 Characteristics of Viral Vector–Based Nanoparticles 1976.3 Applications 1996.4 Novel Advancements in Applications of Viral Nanoparticles 2256.5 Limitations and Prospects of Viral Vector–Based Nanoparticle Approach 2336.6 Conclusion 234 nanomedicine and nano-delivery systems, materials in the nanoscale range are used as diagnostic instruments or to administer therapeutic compounds to particular targeted regions in a controlled manner. By delivering precise medications to specified locations and targets, nanotechnology provides several advantages in treating chronic human illnesses. The use of nanomedicine (including chemotherapeutic medicines, biological agents, immunotherapeutic agents, etc.) in the treatment of various diseases has recently seen many notable applications. This book aims to be a single source material for understanding all the current and novel advancements in the field of nanotechnology

Nanocarrier Vaccines: Biopharmaceutics-Based Fast Track DevelopmentViral Vector–Based Nanoparticles Suneetha Vuppu.

journal of expert reviews on vaccines

infectious Diarrhoea: Therapeutic Management and Vaccination                                                   Chevada,Vuppu ,misra ,Vasso Apostolopoulos

Advanced Vaccination Technologies for Infectious and Chronic DiseasesChapter 9: Expression system and purification process for the vaccine production Suneetha Vuppu

natural resources for human health

Phytochemical-loaded Nanoparticles in COVID-19 Management (NRFHH-00320-2023-02) Suneetha Vuppu

Breast cancer is one of the most common malignancies affecting women worldwide, emphasizing the need for effective therapeutic strategies. Phytochemicals derived from plants have gained significant attention due to their potential anticancer properties.<h3>Objective</h3>This review aims to comprehensively assess the existing literature on using phytochemical-loaded formulations as a therapeutic approach for breast cancer. By analyzing the available evidence, we aim to determine the potential benefits and limitations of these formulations in terms of their anticancer activity, bioavailability, and safety.<h3>Methods</h3>A systematic search of relevant databases was conducted to identify studies investigating phytochemical-loaded formulations in the context of breast cancer treatment. The inclusion criteria encompassed clinical trials, preclinical studies, and in-vitro experiments that reported using phytochemicals in various formulations for breast cancer treatment. Data extraction was performed to ensure the reliability and validity of the included studies.<h3>Results</h3>The review highlights the diverse range of phytochemicals used in different formulations for breast cancer treatment. Findings suggest that these formulations exhibit promising anticancer effects by targeting multiple signaling pathways in breast cancer progression, including cell proliferation, apoptosis, angiogenesis, and metastasis. Moreover, various delivery systems, such as nanoparticles, liposomes, and micelles, have enhanced phytochemicals' bioavailability and targeted delivery.

Clinical Complementary Medicine and Pharmacology

Phytochemical Loaded Nanovehicles of Biopolymer for Breast Cancer: A Systemic ReviewSuneetha and Toshika